Skip to Main Content

Author Details

Mars Stone
Vitalant Research Institute
2003
130
36
PMIDPaper TitleJournal TitlePublished Year
37976448Regulation of kynurenine metabolism by blood donor genetics and biology impacts red cell hemolysis in vitro and in vivo.Blood2024
38054619Clinical outcomes in hospitalized plasma and platelet transfusion recipients prior to and following widespread blood donor SARS-CoV-2 infection and vaccination.Transfusion2024
36862515COVID-19 convalescent plasma boosts early antibody titer and does not influence the adaptive immune response.JCI Insight2023
38019897A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size.PLoS Pathog2023
37662344Administration of vaccine-boosted COVID-19 convalescent plasma to SARS-CoV-2 infected hamsters decreases virus replication in lungs and hastens resolution of the infection despite transiently enhancing disease and lung pathology.bioRxiv2023
37783718Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence.Nat Commun2023
37642154HIV risk behavior profiles among men who have sex with men interested in donating blood: Findings from the Assessing Donor Variability and New Concepts in Eligibility study.Transfusion2023
35687888Surveillance for Zika, Chikungunya, and Dengue Virus Incidence and RNAemia in Blood Donors at 4 Brazilian Blood Centers During 2016-2019.J Infect Dis2023
37250174Prevalence of SARS-CoV-2 Viremia in Presymptomatic Blood Donors in the Delta and Omicron Variant Eras.Open Forum Infect Dis2023
37414788Application of ultrasensitive digital ELISA for p24 enables improved evaluation of HIV-1 reservoir diversity and growth kinetics in viral outgrowth assays.Sci Rep2023
37347180Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications.Microbiol Spectr2023
36695358Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size.AIDS2023
36621777Plasma transfusion-transmission of Zika virus in mice and macaques.Transfusion2023
36469038Sphingosine 1-phosphate has a negative effect on RBC storage quality.Blood Adv2023
36712077Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infection.bioRxiv2023
36930653Standardized evaluation of Zika nucleic acid tests used in clinical settings and blood screening.PLoS Negl Trop Dis2023
34111244Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.Clin Infect Dis2022
35584677A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection.Cell Rep2022
35443018Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation.PLoS Pathog2022
35441384The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.Transfusion2022
35612315Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies.Microbiol Spectr2022
35834347Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasma.J Clin Invest2022
35607854How do we⿦form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?Transfusion2022
35435733Plasma CD16<sup>+</sup> Extracellular Vesicles Associate with Carotid Artery Intima-Media Thickness in HIV<sup>+</sup> Adults on Combination Antiretroviral Therapy.mBio2022
35726756Mitigating the risk of transfusion-transmitted infections with vector-borne agents solely by means of pathogen reduction.Transfusion2022
35696249Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.JAMA2022
35819428Clinical Protection During the First Omicron Wave in Unvaccinated, Convalescent US Adults.JAMA2022
35684973Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021.Clin Infect Dis2022
36366424Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV Infection.Viruses2022
35864104Detection of neutralizing antibodies against multiple SARS-CoV-2 strains in dried blood spots using cell-free PCR.Nat Commun2022
35891406The Impact of Early Antiretroviral Treatment (ART) for HIV on the Sensitivity of the Latest Generation of Blood Screening and Point of Care Assays.Viruses2022
35921537Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States Before the Delta- and Omicron-Associated Surges: A Retrospective Cohort Study of Repeat Blood Donors.J Infect Dis2022
36054476Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patients.Transfusion2022
35879995A diagnostic classifier for gene expression-based identification of early Lyme disease.Commun Med (Lond)2022
35129839Vaccination of COVID-19 convalescent plasma donors increases binding and neutralizing antibodies against SARS-CoV-2 variants.Transfusion2022
35128658Antibody profiles in COVID-19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment.Transfusion2022
35285520Reprogramming of red blood cell metabolism in Zika virus-infected donors.Transfusion2022
35202525Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications.Emerg Infect Dis2022
32241843Donor sex, age and ethnicity impact stored red blood cell antioxidant metabolism through mechanisms in part explained by glucose 6-phosphate dehydrogenase levels and activity.Haematologica2021
33824382Distinct SARS-CoV-2 antibody reactivity patterns in coronavirus convalescent plasma revealed by a coronavirus antigen microarray.Sci Rep2021
33483492SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques.Nat Commun2021
33501953Serosurveillance for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Incidence Using Global Blood Donor Populations.Clin Infect Dis2021
33554362Selecting COVID-19 convalescent plasma for neutralizing antibody potency using a high-capacity SARS-CoV-2 antibody assay.Transfusion2021
33495758Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses.Cell Rep Med2021
34473201Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.JAMA2021
34431691Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.mSphere2021
34724004A novel high performing multiplex immunoassay Multi-HTLV for serological confirmation and typing of HTLV infections.PLoS Negl Trop Dis2021
34121205SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance.Transfusion2021
33980647The Specificity of the Persistent IgM Neutralizing Antibody Response in Zika Virus Infections among Individuals with Prior Dengue Virus Exposure.J Clin Microbiol2021
34232731Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.J Virol2021
  • 1 - 50 of 130

Recommended Authors

Yale School of Public Health
Career Start Year 2019
Number of shared co-authors 0
Yale School of Public Health
Career Start Year 2018
Number of shared co-authors 2
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 3
Sydney Institute for Infectious Diseases, The University of Sydney
Career Start Year 2016
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 2016
Number of shared co-authors 2
Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 1
Yale School of Public Health
Career Start Year 2013
Number of shared co-authors 8
University of Nebraska Medical Center
Career Start Year 2013
Number of shared co-authors 2
Ragon Institute of MGH
Career Start Year 2012
Number of shared co-authors 21
Yale School of Public Health
Career Start Year 2010
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2009
Number of shared co-authors 7
University of Washington Medical Center
Career Start Year 2008
Number of shared co-authors 12
University of Washington
Career Start Year 2007
Number of shared co-authors 2
School of Public Health, Brown University
Career Start Year 2007
Number of shared co-authors 0
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2006
Number of shared co-authors 6
Goethe University Frankfurt, University Hospital, Institute for Medical Virology
Career Start Year 2004
Number of shared co-authors 2
The Rockefeller University
Career Start Year 2002
Number of shared co-authors 1
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 2
University of California San Diego
Career Start Year 2001
Number of shared co-authors 8
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 3
Infectious Disease Clinical Research Program, Uniformed Services University
Career Start Year 2000
Number of shared co-authors 3
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 15
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 5
Harvard University
Career Start Year 1997
Number of shared co-authors 10
Department of Medicine Johns Hopkins Medicine. Baltimore MD 21205USA.
Career Start Year 1996
Number of shared co-authors 7
Centers for Disease Control and Prevention
Career Start Year 1993
Number of shared co-authors 4
USA Carver College of Medicine
Career Start Year 1992
Number of shared co-authors 19
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year 1988
Number of shared co-authors 3
University of Rochester Medical Center
Career Start Year 1983
Number of shared co-authors 4
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Career Start Year 1976
Number of shared co-authors 1

Collaborators

Vitalant Research Institute
Co-authored papers 93
University of British Columbia
Co-authored papers 28
Vitalant Research Institute
Co-authored papers 20
Cerus Corporation
Co-authored papers 16
Co-authored papers 15
Scientific Services
Co-authored papers 15
Yale University
Co-authored papers 13
University of California san francisco
Co-authored papers 13
University of California San Francisco
Co-authored papers 11
Genomics and Translational Research Center
Co-authored papers 10
Vitalant Research Institute
Co-authored papers 10
University of California-San Francisco
Co-authored papers 9
University of Colorado Anschutz Medical Campus
Co-authored papers 9
University of Virginia
Co-authored papers 8
Clinical Services
Co-authored papers 8
University of Maryland School of Medicine
Co-authored papers 7
Co-authored papers 7
College of Forestry, Shenyang Agricultural University
Co-authored papers 7
GeneCentric Therapeutics Inc.
Co-authored papers 6
Vitalant Research Institute
Co-authored papers 6
Clinical Sciences
Co-authored papers 6
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Co-authored papers 5
University of Colorado Anschutz Medical Campus
Co-authored papers 5
University of Colorado Anschutz Medical Campus
Co-authored papers 5
University of California san francisco
Co-authored papers 5
Fred Hutchinson Cancer Center
Co-authored papers 5
Co-authored papers 5
University of CaliforniaSan Francisco
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4